Trial Profile

Clinical Trials Insight: 700053888

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 06 Apr 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clavulanic acid (Primary)
Indications Parkinson's disease
Focus Therapeutic Use
Sponsors Rexahn Pharmaceuticals

Most Recent Events

06 Apr 2010 A phase II protocol for this trial has been submitted to the US Food and Drug Administration, according to a Rexahn Pharmaceuticals media release.
22 Feb 2010 New trial record
18 Feb 2010 The trial is expected to be initiated in the second quarter of 2010, as reported in a Rexahn Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com